Home High Flow Oxygen to Reduce Acute Exacerbation of COPD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Home High Flow Oxygen to Reduce Acute Exacerbation of COPD — Stella

Home/Chronic Obstructive Pulmonary Disease/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Obstructive Pulmonary Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

UHRouen, Rouen

Key details

Sponsor

University Hospital, Rouen

Enrollment target

~406 participants

Started

August 2022

Primary completion

August 2026

Age range

18 Years – 85 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.